View the latest clinical trials, studies, data, and updates.
ReCor Medical notes the data from RADIANCE-II will build on evidence from RADIANCE-HTN SOLO and TRIO studies to support pre-market application to the FDA
HeartPoint Global notes this new milestone follows the company’s successful exploration of the HeartPoint Global Implant System in the arterial branches.
SpineX notes SCONE™, a non-invasive transcutaneous spinal cord neuromodulator is the first of its kind device that is being developed to treat bladder dysfunction.
Hinge Health said a joint study with researchers from UCSF and the University of Rhode Island is the first to demonstrate long-term outcomes of a digital musculoskeletal solution.
In the study, the team analyzed publicly available, real-world data from about 16,000 participants enrolled in the T1D Exchange Clinic Registry.
LFM Healthcare Solutions notes he study also notes that these “adverse-event reports” filed by hospitals, endoscope manufacturers, patients and other stakeholders rose markedly in all categories of studied endoscopes from 2014 to 2021 and continued to “increase significantly” from 2019 to 2020 for urological endoscopes and colonoscopes “when the number of elective or non-urgent endoscopic procedures performed during the pandemic decrease in the U.S. and globally